Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Markov Models in Medical Decision Making: A Practical Guide

Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419

NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN

Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890

Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

SCHIFFMAN, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,197

Epidemiology of Genital Human Papillomavirus Infection

Koutsky, L. A. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,103

A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection

Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940

Screening for Cervical Cancer

Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 841

Meta-analysis of Pap Test Accuracy

Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690

Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women

Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics

Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women

Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562

Economic evaluation of strategies for managing women with equivocal cytological results in Brazil

Vanni, T., Legood, R., Franco, E. L., Villa, L. L., Luz, P. M., & Schwartsmann, G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25708 · Cited by 23

Atypical squamous cells of undetermined significance on cervical smears

Cheung, A., Szeto, E. F., Ng, K.-M., Fong, K.-W., Yeung, A. C. E., Tsun, O. K. L., Khoo, U., Chan, K. Y. K., & Ng, A. W. Y. (2004) · Cancer · doi:10.1002/cncr.20045 · Cited by 23

Cost‐effectiveness of breast cancer screening programme for women in rural China

Sun, L. J., Sadique, Z., dos‐Santos‐Silva, I., Yang, L., & Legood, R. (2018) · International Journal of Cancer · doi:10.1002/ijc.31956 · Cited by 22

Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia

Aponte-González, J., Fajardo-Bernal, L., Díaz, J., Eslava-Schmalbach, J. H., Gamboa, Ó., & Hay, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080639 · Cited by 22

Economic evaluation of human papillomavirus screening in Germany

Mittendorf, T., Petry, K. U., Iftner, T., Greiner, W., & von der Schulenburg, J. G. (2003) · The European Journal of Health Economics · doi:10.1007/s10198-003-0187-0 · Cited by 22

Using simulation-optimization to construct screening strategies for cervical cancer

Albert, L. A., Foufoulides, C., & Merrick, J. R. W. (2010) · Health Care Management Science · doi:10.1007/s10729-010-9131-x · Cited by 24

1999 National Hospital Discharge Survey

Popovic, J. R., & Hall, M. J. (2001) · Cited by 22

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand

Termrungruanglert, W., Khemapech, N., Vasuratna, A., Havanond, P., Deebukkham, P., Kulkarni, A. S., & Pavelyev, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245894 · Cited by 21

Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients

Mennini, F. S., Marcellusi, A., Gitto, L., & Iannone, F. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-016-0491-y · Cited by 21

A Behavioral Economic Approach to Improving Human Papillomavirus Vaccination

Caskey, R. N., Sherman, E. G., Beskin, K., Rapport, R., Xia, Y., & Schwartz, A. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.07.020 · Cited by 22

Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women

Panotopoulou, E., Tserkezoglou, A., Kouvousi, M., Tsiaousi, I., Chatzieleftheriou, G., Daskalopoulou, D., & Magiakos, G. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21025 · Cited by 21

Untitled work

(2012) · doi:10.3332/ecancer.2012.258 · Cited by 20

CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer

Chatterjee, K., Williamson, A., Hoffman, M. N., & Dandara, C. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22009 · Cited by 20

Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation

Peron, M., Llewellyn, A., Moe‐Byrne, T., Walker, S., Walton, M., Harden, M., Palmer, S., & Simmonds, M. C. (2018) · Health Technology Assessment · doi:10.3310/hta22540 · Cited by 20

Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany

Hillemanns, P., Petry, K. U., Largeron, N., McAllister, R., Tolley, K. H., & Büsch, K. (2008) · Journal of Public Health · doi:10.1007/s10389-008-0228-3 · Cited by 21

Analysis of Risk-Structured Vaccination Model for the Dynamics of Oncogenic and Warts-Causing HPV Types

Alsaleh, A. A., & Gumel, A. B. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-014-9972-4 · Cited by 20

HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer

Roy, S., & Shankar, A. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.9.2357 · Cited by 20

Novel Health Economic Evaluation of a Vaccination Strategy to Prevent HPV-related Diseases

Favato, G., Baio, G., Capone, A., Marcellusi, A., Costa, S., Garganese, G., Picardo, M., Drummond, M., Jönsson, B., Scambia, G., et al. (2012) · Medical Care · doi:10.1097/mlr.0b013e318269e06d · Cited by 21

Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia

Obradović, M., Mrhar, A., & Kos, M. (2010) · European Journal of Public Health · doi:10.1093/eurpub/ckp208 · Cited by 19

Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis

Accetta, G., Biggeri, A., Carreras, G., Lippi, G., Carozzi, F., Confortini, M., Zappa, M., & Paci, E. (2010) · Journal of Medical Screening · doi:10.1258/jms.2010.010019 · Cited by 19

Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening

Viscondi, J. Y. K., Faustino, C. G., Campolina, A. G., Itria, A., & de Soárez, P. C. (2018) · Clinics · doi:10.6061/clinics/2018/e385 · Cited by 19

Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China

Hu, S., Rezhake, R., Chen, F., Zhang, X., Pan, Q., Ma, J., Qiao, Y., & Zhao, F. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.12.027 · Cited by 19

The cost‐effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?

Anderson, R., Haas, M. R., & Shanahan, M. (2008) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2008.00165.x · Cited by 19

Dissemination of Evidence-based Practice Center Reports

Matchar, D. B., Westermann-Clark, E. V., McCrory, D. C., Patwardhan, M., Samsa, G. P., Kulasingam, S., Myers, E., Sarría‐Santamera, A., Lee, A., Gray, R., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_2-200506211-00012 · Cited by 19

Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial

Montealegre, J. R., Anderson, M. L., Hilsenbeck, S. G., Chiao, E. Y., Cantor, S. B., Parker, S., Daheri, M., Bulsara, S., Escobar, B., Deshmukh, A. A., et al. (2020) · Trials · doi:10.1186/s13063-020-04790-5 · Cited by 19

DYNAMICS ANALYSIS OF A VACCINATION MODEL FOR HPV TRANSMISSION

Alsaleh, A. A., & Gumel, A. B. (2014) · Journal of Biological Systems · doi:10.1142/s0218339014500211 · Cited by 18

Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer

Klosky, J. L., Russell, K. M. W., Simmons, J. L., Foster, R. H., Peck, K. R., Green, D. M., & Hudson, M. M. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25539 · Cited by 18

Cervical cancer screening

Wiley, D. J., Monk, B. J., Masongsong, E. V., & Morgan, K. (2004) · Current Oncology Reports · doi:10.1007/s11912-004-0083-5 · Cited by 18

Cost-effectiveness of a patient navigation program to improve cervical cancer screening.

Li, Y., Carlson, E., Villarreal, R. E., Meraz, L., & Pagán, J. A. (2017) · PubMed · Cited by 17

The diversity of vaginal microbiome in women infected with single HPV and multiple genotype HPV infections in China

Liu, S., Li, Y., Song, Y., Wu, X., Baloch, Z., & Xia, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.642074 · Cited by 17

Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study

Zhao, X., Zhao, S., Xia, C., Hu, S., Duan, X., Liu, Z., Wang, Y., You, T.-T., Gao, M., Qiao, Y., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02840-8 · Cited by 18

Will vaccination against human papillomavirus prevent eye disease? A review of the evidence

Hughes, D. S., Powell, N., & Fiander, A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.135038 · Cited by 17

Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer

Nghiem, V. T. H., Davies, K., Beck, J. R., Follen, M. M., & Cantor, S. B. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1044 · Cited by 17

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening

Nghiem, V. T. H., Davies, K., Beck, J. R., Follen, M. M., MacAulay, C. E., Guillaud, M. D., & Cantor, S. B. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.95 · Cited by 17

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

Marle, M. E. V. D. A., van Ballegooijen, M., Rozendaal, L., Meijer, C. J. L. M., & Habbema, J. D. F. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601355 · Cited by 17

Sequence-Dependent Interaction of the Human Papillomavirus E2 Protein with the DNA Elements on Its DNA Replication Origin

Yılmaz, G., Biswas, E. E., & Biswas, S. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076555 · Cited by 16

Present and future of cervical cancer prevention in Spain: a cost-effectiveness analysis

Georgalis, L., de Sanjosé, S., Esnaola, M., Bosch, F. X., & Díaz, M. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000202 · Cited by 16

A Markov Decision Process Model for Cervical Cancer Screening Policies in Colombia

Akhavan‐Tabatabaei, R., Sánchez, D. M., & Yeung, T. G. (2016) · Medical Decision Making · doi:10.1177/0272989x16670622 · Cited by 16

A hidden Markov model for population‐level cervical cancer screening data

Soper, B., Nygård, M., Abdulla, G. M., Meng, R., & Nygård, J. F. (2020) · Statistics in Medicine · doi:10.1002/sim.8681 · Cited by 16

Virally mediated cervical cancer in the iatrogenically immunocompromised: Applications for psychoneuroimmunology

Jensen, S. E., Lehman, B., Antoni, M. H., & Pereira, D. B. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.01.003 · Cited by 16

Perceptions of and preferences for federally-funded family planning clinics

Oglesby, W. H. (2014) · Reproductive Health · doi:10.1186/1742-4755-11-50 · Cited by 16

Análisis de coste-efectividad de la vacunación frente al virus del papiloma humano tipos 6, 11, 16 y 18 en España

Largeron, N., Rémy, V., Oyee, J., Martin, M., Cortés, J., & Olmos, L. (2008) · Vacunas · doi:10.1016/s1576-9887(08)71915-0 · Cited by 17

Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis

MESSOUDI, W., Mahi, T. E., Nejjari, C., Tachfouti, N., Zidouh, A., Saadani, G., Moriña, D., & Díaz, M. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1624556 · Cited by 15

Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model

Shafer, L. A., Jeffrey, I., Elias, B., Shearer, B. D., Canfell, K., & Kliewer, E. V. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.073 · Cited by 15

Cost-Effectiveness of HPV-Vaccination in Medium or Low Income Countries with High Cervical Cancer Incidence – A Systematic Review

Natunen, K. (2013) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000172 · Cited by 15

Swedish women’s awareness of human papillomavirus, and health-related quality of life, anxiety, and depression after a notification of an abnormal Pap smear result: a cross-sectional study

Rask, M., Swahnberg, K., & Oscarsson, M. G. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000430 · Cited by 15

Vulvar Intraepithelial Neoplasia (VIN) and Condylomata

Nelson, E. L., Bogliatto, F., & Stockdale, C. K. (2015) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000132 · Cited by 15

Effects of Multimedia Framed Messages on Human Papillomavirus Prevention Among Adolescents

Tu, Y., Lin, Y.-J., Fan, L., Tsai, T., & Wang, H. (2018) · Western Journal of Nursing Research · doi:10.1177/0193945918763873 · Cited by 15

New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent

Fishbein, D. B., Broder, K. R., Markowitz, L. E., & Messonnier, N. E. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1115b · Cited by 15

Cervical cancer stigma – A silent barrier to the elimination of cervical cancer

Bae, H. S., & Temkin, S. M. (2025) · Cancer · doi:10.1002/cncr.35776 · Cited by 14

Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity

Lee, E., Lavieri, M. S., Volk, M. L., & Xu, Y. (2014) · Health Care Management Science · doi:10.1007/s10729-014-9304-0 · Cited by 14

Ethnic Differences in Predictors of HPV Vaccination: Comparisons of Predictors for Latina and Non-Latina White Women

Reimer, R. A., Houlihan, A. E., Gerrard, M., Deer, M., & Lund, A. J. (2012) · The Journal of Sex Research · doi:10.1080/00224499.2012.692406 · Cited by 14

The lifetime cost estimation of human papillomavirus-related diseases in China: a modeling study

Ding, W., Ma, Y., Ma, C., Malone, D. C., Ma, A., Tang, W., & Si, L. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0039 · Cited by 14

A Potential Error in Evaluating Cancer Screening: A Comparison of 2 Approaches for Modeling Underlying Disease Progression

Goldie, S. J., & Kuntz, K. M. (2003) · Medical Decision Making · doi:10.1177/0272989x03023003005 · Cited by 14

Beyond the Pap: Assessing Patients' Priorities for the Annual Examination

Becker, H. I., Longacre, M. R., & Harper, D. M. (2004) · Journal of Women s Health · doi:10.1089/jwh.2004.13.791 · Cited by 14

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting

Termrungruanglert, W., Khemapech, N., Vasuratna, A., Havanond, P., & Tantitamit, T. (2024) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2024.35.e85 · Cited by 15

Perceived Risk of Human Papillomavirus Infection and Cervical Cancer among Adolescent Women in Taiwan

Lin, Y.-J., Fan, L.-W., & Tu, Y. (2016) · Asian Nursing Research · doi:10.1016/j.anr.2016.01.001 · Cited by 13

Research for development of an optimal policy strategy for prevention and control of cervical cancer in Thailand

Tangcharoensathien, V., Limwattananon, S., Chaugwon, R., Praditsitthikorn, N., Teerawattananon, Y., & Tantivess, S. (2008) · Cited by 13

Mechanistic mathematical models: An underused platform for HPV research

Ryser, M. D., Gravitt, P. E., & Myers, E. R. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.01.004 · Cited by 14

The HPV test in cervical screening: a brave new world?

Desai, M., & Cubie, H. (2005) · Cytopathology · doi:10.1111/j.1365-2303.2005.00237.x · Cited by 13

Cyberchondria levels in women with human papilloma virus

ÇAKIR, A. T. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15354 · Cited by 12

HPV Knowledge and Factors Associated with Intention to Use Condoms for Reducing HPV Infection Risk among Adolescent Women in Taiwan

Tu, Y., Wang, H., Lin, Y.-J., & Chan, T. (2015) · Women & Health · doi:10.1080/03630242.2014.979970 · Cited by 12

Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening

Ting, J., Smith, J. S., & Myers, E. R. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000143 · Cited by 12

Modélisation de l’impact de la vaccination HPV quadrivalente en France

Riethmuller, D., Prétet, J., Denis, F., Aubin, F., Pradat, P., Clavel, C., Dachez, R., Gondry, J., Carcopino, X., & Mougin, C. (2009) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2009.04.008 · Cited by 12

Impact of model calibration on cost-effectiveness analysis of cervical cancer prevention

Moriña, D., de Sanjosé, S., & Díaz, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-17215-2 · Cited by 12

Prophylactic Human Papillomavirus Vaccination: A Breakthrough in Primary Cervical Cancer Prevention

García, F., & Saslow, D. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.007 · Cited by 12

Building on the pastVisions of housing futures

Malpass, P., & Cairncross, L. (2006) · Policy Press eBooks · doi:10.1332/policypress/9781861347510.001.0001 · Cited by 12

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries

Simonella, L., & Canfell, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.048 · Cited by 11

Young Gay Men and the Quadrivalent Human Papillomavirus Vaccine--Much to Gain (and Lose)

Cranston, R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit627 · Cited by 11

Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in Finland

Castro, F. A., Haimila, K., Pasanen, K., Kaasila, M., Patama, T., Partanen, J., Surcel, H., Pukkala, ­., & Lehtinen, M. (2007) · International Journal of STD & AIDS · doi:10.1258/095646207782193803 · Cited by 11

Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa

Dreyer, G., Maske, C. P., & Stander, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221495 · Cited by 11

MSMB gene variant alters the association between prostate cancer and number of sexual partners

Stott‐Miller, M., Wright, J. L., & Stanford, J. L. (2013) · The Prostate · doi:10.1002/pros.22719 · Cited by 11

Fostering acceptance of human papillomavirus vaccines.

Dekker, A. H. (2006) · PubMed · Cited by 11

Evaluation of the Economic Impact Produced by the Prevention of Events Induced by the HPV 6-11 Virus Types Contained in the Quadrivalent VaccinePreprint

Costa, S., & Favato, G. (2008) · SSRN Electronic Journal · doi:10.2139/ssrn.1080113 · Cited by 11

What cancers explain the growing rural‐urban gap in human papillomavirus‐associated cancer incidence?

Semprini, J., Zahnd, W. E., & Brandt, H. M. (2025) · The Journal of Rural Health · doi:10.1111/jrh.12915 · Cited by 10

HPV transmission and optimal control of cervical cancer in China

Ren, H., Xu, R., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-05514-y · Cited by 10

Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective

Regan, D. G., Philp, D. J., & Waters, E. K. (2010) · Sexual Health · doi:10.1071/sh10006 · Cited by 10

Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea

Lee, T.-H., Kim, W., Shin, J., Park, E., Park, S., & Kim, T. H. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.525 · Cited by 11

Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review)

de Castro (2010) · Oncology Reports · doi:10.3892/or_00001001 · Cited by 10

The impact of cytology screening and HPV vaccination on the burden of cervical cancer

Tay, K., & Tay, S. K. (2011) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2011.01396.x · Cited by 11

Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan

Connelly, L. B., & Le, H. (2015) · Sexual Health · doi:10.1071/sh14241 · Cited by 10

Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates

Ginindza, T. G., & Sartorius, B. K. D. (2018) · BMC Cancer · doi:10.1186/s12885-018-4540-1 · Cited by 10

Models of cervical screening in the era of human papillomavirus vaccination

Canfell, K. (2010) · Sexual Health · doi:10.1071/sh10016 · Cited by 10

Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province

Shi, J. F., Guan, Y., Liang, D., Li, D., He, Y., & Liu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-29985-z · Cited by 9

A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer

Hillyar, C., Kanabar, S. S., Pufal, K. R., Hee, J. L. S., Lawson, A. W., Mohamed, Y., Jasim, D., Reed, L., Rallis, K. S., & Nibber, A. (2023) · Epigenomics · doi:10.2217/epi-2023-0183 · Cited by 10

Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians

Dwivedi, P., Lahariya, A. U., Pandey, S., Sreedevi, A., Lohiya, A., & Lahariya, C. (2024) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_16_23 · Cited by 9

An exploration of human papillomavirus‐related cervical cancer prevention experiences among college women: a descriptive qualitative approach

Tu, Y., & Wang, H. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12051 · Cited by 9

Gesichertes und Neues bei der Therapie von Condylomata

Schneede, P., & Waidelich, R. M. (2013) · Der Urologe · doi:10.1007/s00120-013-3174-9 · Cited by 9

Mathematical Model of HPV Provides Insight into Impacts of Risk Factors and Vaccine

Kim, J. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030164 · Cited by 9

Cost-effectiveness of a cervical screening program with human papillomavirus vaccine

Sopina, L., & Ashton, T. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462311000456 · Cited by 9

Psychosocial and economic aspects of a trial of management of mild and borderline cervical abnormalities (TOMBOLA)

Philips, Z., Gray, N., Avis, M., & Whynes, D. K. (2002) · European Journal of Oncology Nursing · doi:10.1054/ejon.2001.0159 · Cited by 9

Modelos matemáticos para la evaluación económica: los modelos dinámicos basados en ecuaciones diferenciales

Pradas, R., Antoñanzas, F., & Mar, J. (2009) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2008.12.007 · Cited by 9

Exploring the role of the vaginal microbiome in HPV infection dynamics: A prospective cohort study

Liu, Y., Li, R., Liu, J., Liang, X., Su, M., Wang, S., & Mu, B. (2025) · iScience · doi:10.1016/j.isci.2025.112476 · Cited by 8

Usefulness Analysis of Urine Samples for Early Screening of Human Papilloma Virus Infection

Choi, Y. S., Jin, H., & Lee, K. E. (2019) · Journal of Cancer Prevention · doi:10.15430/jcp.2019.24.4.240 · Cited by 8

The Relationship Between Receiving Care Within a Medical Home and HPV Vaccine Receipt for Adolescent Girls: Results of the 2007 National Survey of Children’s Health

Test, F. S., Caskey, R. N., & Rankin, K. (2012) · Maternal and Child Health Journal · doi:10.1007/s10995-012-0975-1 · Cited by 8

Impact of Dietary Quality on Genital Oncogenic Human Papillomavirus Infection in Women

Lin, H., Fu, Q., Tseng, T., Zhu, X., Reiss, K., Su, L., & Hagensee, M. E. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad146 · Cited by 8

Conhecimento de mulheres sobre alguns aspectos do papiloma vírus humano

Pimenta, A. T. M., Melli, P. P. D. S., Duarte, G. G., & Quintana, S. M. (2014) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v47i2p143-148 · Cited by 8

Human papillomavirus in adolescents: Lessons learned from decades of evaluation

Jayasinghe, Y., Moore, E. E., Tabrizi, S. N., Grover, S. R., & Garland, S. M. (2011) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2011.02073.x · Cited by 8

A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection

Miller, A., Münger, K., & Adler, F. R. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0299-9 · Cited by 8

Application of Dynamic Bayesian Networks to cervical cancer screening

Oniśko, A., Drużdżel, M. J., & Austin, R. M. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 8

An updated natural history model of cervical cancer: derivation of model parameters

Campos, N. G., Burger, E. A., Sy, S., Sharma, M., Schiffman, M., Rodriguez, A. C., Hildesheim, A., Herrero, R., & Kim, J. J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu159 · Cited by 116

Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands

Berkhof, J. H., de Bruijne, M. C., Zielinski, G. D., & Meijer, C. J. L. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20846 · Cited by 42

Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data

Jit, M., Gay, N. J., Soldan, K., Choi, Y. H., & Edmunds, W. J. (2009) · Medical Decision Making · doi:10.1177/0272989x09336140 · Cited by 40

Prevention of cancers caused by infection with human papillomavirus types: modelling of the natural history of HPV infection

Bláha, O. (2010) · Document Server@UHasselt (UHasselt)

Multiparameter calibration of a natural history model of cervical cancer

Kim, J. J., Kuntz, K. M., Stout, N. K., Mahmud, S., Villa, L. L., Franco, E. L., & Goldie, S. J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm086 · Cited by 161